WORK Medical Technology Group (NASDAQ:WOK – Get Free Report) and Pulse Biosciences (NASDAQ:PLSE – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations and earnings.
Risk & Volatility
WORK Medical Technology Group has a beta of 3.5, meaning that its stock price is 250% more volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.73, meaning that its stock price is 73% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings for WORK Medical Technology Group and Pulse Biosciences, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| WORK Medical Technology Group | 1 | 0 | 0 | 0 | 1.00 |
| Pulse Biosciences | 1 | 0 | 2 | 0 | 2.33 |
Earnings & Valuation
This table compares WORK Medical Technology Group and Pulse Biosciences”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| WORK Medical Technology Group | $9.81 million | 0.00 | -$1.07 million | N/A | N/A |
| Pulse Biosciences | $350,000.00 | 4,065.80 | -$72.78 million | ($1.08) | -19.38 |
WORK Medical Technology Group has higher revenue and earnings than Pulse Biosciences.
Institutional & Insider Ownership
77.0% of Pulse Biosciences shares are held by institutional investors. 74.6% of Pulse Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares WORK Medical Technology Group and Pulse Biosciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| WORK Medical Technology Group | N/A | N/A | N/A |
| Pulse Biosciences | N/A | -73.77% | -63.98% |
Summary
Pulse Biosciences beats WORK Medical Technology Group on 6 of the 11 factors compared between the two stocks.
About WORK Medical Technology Group
WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.
About Pulse Biosciences
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Receive News & Ratings for WORK Medical Technology Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WORK Medical Technology Group and related companies with MarketBeat.com's FREE daily email newsletter.
